Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126969822 | 12696982 | 2 | F | 201608 | 20160908 | 20160830 | 20160915 | EXP | CA-ALEXION PHARMACEUTICALS INC-A201606323 | ALEXION | 55.43 | YR | M | Y | 63.50000 | KG | 20160915 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126969822 | 12696982 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | AAD9299B04 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 126969822 | 12696982 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | AE1229B05 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 126969822 | 12696982 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | AE7317B04 | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 126969822 | 12696982 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 126969822 | 12696982 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 35 MG, UNK | 0 | 35 | MG | ||||||||
| 126969822 | 12696982 | 6 | C | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 40 ?G, Q2W | 0 | 40 | UG | QOW | |||||||
| 126969822 | 12696982 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 126969822 | 12696982 | 8 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | Oral | 100 MG, BID | 0 | 100 | MG | BID | |||||||
| 126969822 | 12696982 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 126969822 | 12696982 | 10 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 650 MG, PRN | 0 | 650 | MG | /yr | |||||||
| 126969822 | 12696982 | 11 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126969822 | 12696982 | 12 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0.5 MG, PRN | 0 | .5 | MG | /yr | |||||||
| 126969822 | 12696982 | 13 | C | MAGNESIUM COMPLEXE | MAGNESIUM | 1 | Oral | 250 MG, BID | 0 | 250 | MG | BID | |||||||
| 126969822 | 12696982 | 14 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 126969822 | 12696982 | 15 | C | REPAGLINIDE. | REPAGLINIDE | 1 | Oral | 0.5 MG, QD | 0 | .5 | MG | QD | |||||||
| 126969822 | 12696982 | 16 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 126969822 | 12696982 | 17 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1200 ?G, QD | 0 | 1200 | UG | QD | |||||||
| 126969822 | 12696982 | 18 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 0.25 ?G, QD | 0 | .25 | UG | QD | |||||||
| 126969822 | 12696982 | 19 | C | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | Oral | 360 MG, BID | 0 | 360 | MG | BID | |||||||
| 126969822 | 12696982 | 20 | C | NEORAL | CYCLOSPORINE | 1 | Oral | 250 MG, BID | 0 | 250 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126969822 | 12696982 | 1 | Haemolytic uraemic syndrome |
| 126969822 | 12696982 | 4 | Product used for unknown indication |
| 126969822 | 12696982 | 6 | Product used for unknown indication |
| 126969822 | 12696982 | 7 | Product used for unknown indication |
| 126969822 | 12696982 | 8 | Hypertension |
| 126969822 | 12696982 | 9 | Hypertension |
| 126969822 | 12696982 | 10 | Product used for unknown indication |
| 126969822 | 12696982 | 11 | Pain |
| 126969822 | 12696982 | 12 | Anxiolytic therapy |
| 126969822 | 12696982 | 13 | Vitamin supplementation |
| 126969822 | 12696982 | 14 | Prophylaxis |
| 126969822 | 12696982 | 15 | Diabetes mellitus |
| 126969822 | 12696982 | 16 | Vitamin supplementation |
| 126969822 | 12696982 | 17 | Vitamin supplementation |
| 126969822 | 12696982 | 18 | Vitamin supplementation |
| 126969822 | 12696982 | 19 | Immunosuppressant drug therapy |
| 126969822 | 12696982 | 20 | Immunosuppressant drug therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126969822 | 12696982 | HO |
| 126969822 | 12696982 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126969822 | 12696982 | Blood creatinine increased | |
| 126969822 | 12696982 | Blood glucose fluctuation | |
| 126969822 | 12696982 | Bone pain | |
| 126969822 | 12696982 | Nausea | |
| 126969822 | 12696982 | Pain in extremity | |
| 126969822 | 12696982 | Transplant rejection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126969822 | 12696982 | 1 | 20160602 | 20160623 | 0 | |
| 126969822 | 12696982 | 2 | 20160602 | 20160623 | 0 | |
| 126969822 | 12696982 | 3 | 20160630 | 0 | ||
| 126969822 | 12696982 | 5 | 20160825 | 0 | ||
| 126969822 | 12696982 | 6 | 20160510 | 0 | ||
| 126969822 | 12696982 | 15 | 201301 | 0 | ||
| 126969822 | 12696982 | 19 | 201301 | 0 | ||
| 126969822 | 12696982 | 20 | 20160822 | 0 |